Harrow Health Inc (NASDAQ:HROW)
| 18.44 Delayed Data As of Mar 24 |  +1.17 / +6.78%Today’s Change | 5.40 Today|||52-Week Range 20.31 | +24.93% Year-to-Date |
Latest HROW News | Press Releases
No recent news for Harrow Health Inc.
Today’s Trading
| Previous close | 17.25 |
| Today’s open | 18.14 |
| Day’s range | 17.16 - 18.58 |
| Volume | 392,490 |
| Average volume (3 months) | 308,633 |
| Market cap | $550.2M |
Data as of 3:59pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +26.15% |
| Earnings growth (this year) | +174.51% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +22.24% |
| P/E ratio | NM |
| Price/Sales | 4.58 |
| Price/Book | 19.96 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ICPTIntercept Pharmaceut... | -0.23 | -1.68% |
| CTICCTI Biopharma Corp | 0.00 | 0.00% |
| ACRSAclaris Therapeutics... | -0.14 | -1.72% |
| ---- |
Data as of 3:59pm ET, 03/24/2023
Financials
| Next reporting date | May 16, 2023 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $88.6M |
| Annual profit (last year) | -$14.1M |
| Net profit margin | -15.90% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Nashville, Tennessee |
Forecasts
